Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ULTRA-LEVURA 50 MG CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/ULTRA-LEVURA 50 MG CAPSULAS DURAS

Approved

STANDARD

ULTRA-LEVURA 50 MG CAPSULAS DURAS

Biocodex🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jul 23, 2020
Approval ID: b53fef477bc3d313
Company: Biocodex
Type: Standard

Approval Details

Approval Id: b53fef477bc3d313
Drug Cima Aemps Name: ULTRA-LEVURA 50 MG CAPSULAS DURAS
Register Number: 62989610
Holder Company Name: Biocodex
Marketing Company Name: Elam Pharma Labs S.L.
Holder Company Detail Path: /organization/biocodex
Authorization Date: 2020-07-23
Dosage Form: CÁPSULA DURA
Dose: 50 mg
Route Of Administration: VÍA ORAL
Prescription Type: Sin Receta
Commercialized: Yes
Company Name: Biocodex
Company Detail Path: /organization/biocodex

Company Information

Pharmaceutical Company Name: BIOCODEX
Country Name: France
City Name: gentilly,ile de france,country_fr
Address: 22 RUE DES AQUEDUCS

Active Ingredients

SACCHAROMYCES BOULARDII CNCM I-745

50 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 23, 2020

Approval ID

b53fef477bc3d313

Type

Standard

Back to CIMA-AEMPS Approvals